Estimating Local Costs Associated with Clostridium difficile Infection Using Machine Learning and Electronic Medical Records

Infection Control and Hospital Epidemiology

Volumn 38, Issue 12, 2017, Pages 1478-1486

  Pak, Theodore R ^a   Chacko, Kieran I ^a   O'Donnell, Timothy ^a   Huprikar, Shirish S ^a   Van Bakel, Harm ^a   Kasarskis, Andrew ^a   Scott, Erick R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM TOXIN; NUCLEIC ACID;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; ENZYME IMMUNOASSAY; FECES ANALYSIS; FEMALE; HEALTH CARE COST; HEALTHCARE ASSOCIATED INFECTION; HUMAN; ICD-9; INFECTION RISK; LABORATORY TEST; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; RETROSPECTIVE STUDY; VERY ELDERLY; ADOLESCENT; CLOSTRIDIUM INFECTION; CROSS INFECTION; ECONOMICS; ELECTRONIC HEALTH RECORD; MIDDLE AGED; NEW YORK; PEPTOCLOSTRIDIUM DIFFICILE; PROPENSITY SCORE; STATISTICAL MODEL; TERTIARY CARE CENTER; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; ELECTRONIC HEALTH RECORDS; FEMALE; HEALTH CARE COSTS; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; MACHINE LEARNING; MALE; MIDDLE AGED; NEW YORK; PROPENSITY SCORE; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 85033371762     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2017.214     Document Type: Article

References (44)

1. Leffler DA, Lamont JT. Clostridium difficile. N Engl J Med 2015;372:1539-1548.
2. Davies KA, Longshaw CM, Davis GL, et al. Underdiagnosis of Clostridium difficile across Europe: The European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis 2014;14:1208-1219.
3. Zimlichman E, Henderson D, Tamir O, et al. Health careassociated infections: A meta-Analysis of costs and financial impact on the US health care system. JAMA Intern Med 2013;173:2039-2046.
4. Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW. Economic healthcare costs of Clostridium difficile infection: A systematic review. J Hosp Infect 2010;74:309-318.
5. Zhang S, Palazuelos-Munoz S, Balsells EM, Nair H, Chit A, Kyaw MH. Cost of hospital management of Clostridium difficile infection in United States-A meta-Analysis and modelling study. BMC Infect Dis 2016;16:447.
6. Gabriel L, Beriot-Mathiot A. Hospitalization stay and costs attributable to Clostridium difficile infection: A critical review. J Hosp Infect 2014;88:12-21.
7. Stevens VW, Khader K, Nelson RE, et al. Excess length of stay attributable to Clostridium difficile infection (CDI) in the acute care setting: A multistate model. Infect Control Hosp Epidemiol 2015;36:1-7.
8. Lofgren ET, Cole SR, Weber DJ, Anderson DJ, Moehring RW. Hospital-Acquired Clostridium difficile infections: estimating allcause mortality and length of stay. Epidemiology 2014;25:570-575.
9. Katz MH. Pay for preventing (not causing) health care-Associated infections. JAMA Intern Med 2013;173:2046.
10. Dubberke ER, Carling P, Carrico R, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014;35:628-645.
11. Cooper Z, Craig S, Gaynor M, Van Reenen J. The price ain?t right? Hospital prices and health spending on the privately insured. NBER Working Paper No. 21815; 2015.
12. Dubberke ER, Schaefer E, Reske KA, ZilberbergM, Hollenbeak CS, Olsen MA. Attributable inpatient costs of recurrent Clostridium difficile infections. Infect Control Hosp Epidemiol 2014;35: 1400-1407.
13. Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ. Short-And long-Term attributable costs of Clostridium difficileassociated disease in nonsurgical inpatients. Clin Infect Dis 2008;46:497-504.
14. Greco G, Shi W, Michler RE, et al. Costs associated with health care-Associated infections in cardiac surgery. J Am Coll Cardiol 2015;65:15-23.
15. Henry J, Pylypchuk Y, Searcy T, Patel V. Adoption of electronic health record systems among U.S. non-federal acute care hospitals: 2008-2015. Health Information Technology Dashboard website. https://dashboard.healthit.gov/evaluations/data-briefs/non-federal-Acute-care-hospital-ehr-Adoption-2008-2015.php. Published 2016. Accessed September 21, 2017.
16. Gray BH, Bowden T, Johansen I, Koch S. Electronic health records: An international perspective on "meaningful use." Issue Brief (Commonw Fund) 2011;28:1-18.
17. Etheredge LM. A rapid-learning health system. Health Aff (Millwood) 2007;26:w107-w118.
18. Dahabreh IJ, Kent DM. Can the learning health care system be educated with observational data? JAMA 2014;312:129-130.
19. Pak TR, Kasarskis A. How next-generation sequencing and multiscale data analysis will transform infectious disease management. Clin Infect Dis 2015;61:1695-1702.
20. Krumholz HM, Terry SF, Waldstreicher J. Data acquisition, curation, and use for a continuously learning health system. JAMA 2016;316:1669.
21. Wilcox MH, Cunniffe JG, Trundle C, Redpath C. Financial burden of hospital-Acquired Clostridium difficile infection. J Hosp Infect 1996;34:23-30.
22. McGlone SM, Bailey RR, Zimmer SM, et al. The economic burden of Clostridium difficile. Clin Microbiol Infect 2012;18:282-289.
23. Wiens J, Campbell W. Learning data-driven patient risk stratification models for Clostridium difficile. Open Forum Infect Dis 2014;1:1-9.
24. Mitchell BG, Gardner A, Barnett AG, Hiller JE, Graves N. The prolongation of length of stay because of Clostridium difficile infection. Am J Infect Control 2014;42:164-167.
25. Polage CR, Gyorke CE, Kennedy MA, et al. Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA Intern Med 2015;175:1-10.
26. Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults. JAMA 2015;313:398.
27. Moehring RW, Lofgren ET, Anderson DJ. Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-Associated incidence rates. Infect Control Hosp Epidemiol 2013;34:1055-1061.
28. Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 2011;10:150-161.
29. Li YP, Propert KJ, Rosenbaum PR. Balanced risk set matching. J Am Stat Assoc 2001;96:870-882.
30. van Kleef E, Green N, Goldenberg SD, et al. Excess length of stay and mortality due to Clostridium difficile infection: A multi-state modelling approach. J Hosp Infect 2014;88:213-217.
31. Longtin Y, Paquet-Bolduc B, Gilca R, et al. Effect of detecting and isolating Clostridium difficile carriers at hospital admission on the incidence of C difficile infections: A quasi-experimental controlled study. JAMA Intern Med 2016;176:796-804.
32. Dubberke ER, Reske KA, McDonald LC, Fraser VJ. ICD-9 codes and surveillance for Clostridium difficile-Associated disease. Emerg Infect Dis 2006;12:1576-1579.
33. Scheurer DB, Hicks LS, Cook EF, Schnipper JL. Accuracy of ICD-9 coding for Clostridium difficile infections: A retrospective cohort. Epidemiol Infect 2007;135:1010-1013.
34. Rhee C, Murphy M V, Li L, Platt R, Klompas M. Improving documentation and coding for acute organ dysfunction biases estimates of changing sepsis severity and burden: A retrospective study. Crit Care 2015;19:1-11.
35. Romano PS, Mark DH. Bias in the coding of hospital discharge data and its implications for quality assessment. Med Care 1994;32:81-90.
36. Graves N, Harbarth S, Beyersmann J, Barnett A, Halton K, Cooper B. Estimating the cost of health care-Associated infections: mind your p?s and q?s. Clin Infect Dis 2010;50: 1017-1021.
37. Dubberke ER, Yan Y, Reske KA, et al. Development and validation of a Clostridium difficile infection risk prediction model. Infect Control Hosp Epidemiol 2011;32:360-366.
38. Tanner J, Khan D, Anthony D, Paton J. Waterlow score to predict patients at risk of developing Clostridium difficile-Associated disease. J Hosp Infect 2009;71:239-244.
39. Rodrigues R, Barber GE, Ananthakrishnan AN. A comprehensive study of costs associated with recurrent Clostridium difficile infection. Infect Control Hosp Epidemiol 2016:1-7.
40. Pearl J. Myth, confusion, and science in causal analysis. Technical Report R-348, University of California website. http://ftp.cs.ucla. edu/pub/stat-ser/r348.pdf. Published 2009. Accessed September 21, 2017.
41. Lonjon G, Boutron I, Trinquart L, et al. Comparison of treatment effect estimates from prospective nonrandomized studies with propensity score analysis and randomized controlled trials of surgical procedures. Ann Surg 2014;259:18-25.
42. Athey S, Imbens GW, Wager S. Approximate residual balancing: de-biased inference of average treatment effects in high dimensions. arXiv. Cornell University Library website. http://arxiv.org/abs/1604.07125. Published 2016. Accessed September 21, 2017.
43. Antonelli J, Cefalu M, Palmer N, Agniel D. Doubly robust matching estimators for high dimensional confounding adjustment. arXiv. Cornell University Library website. http://arxiv.org/abs/1612.00424. Published 2016. Accessed September 21, 2017.
44. Halpin T, Morgan T. Information modeling and relational databases. 2nd ed. Elsevier Science; 2010.